Literature DB >> 30895818

Environmental health in the biology century: Transitions from population to personalized prevention.

John D Groopman1.   

Abstract

IMPACT STATEMENT: There is a rapidly occurring, dynamic change, in the causes of morbidity and mortality in different populations across the globe. More people today are being diagnosed and treated for chronic diseases such as cancer, cardiovascular disease, and diabetes than ever before. Environmental exposures across the lifespan have a profound impact on the outcomes of these chronic diseases. Further, there are more people living today who have survived their therapy from these diagnoses and who are now differentially susceptible to environmental exposures. Collectively, this poses both the challenge and opportunity to the experimental biology and medicine community to build new models that reflect this changing human situation. The extraordinary advances in our understanding of the biology of disease provide extraordinary insights for both therapeutic and prevention strategies. Multidisciplinary teams including biological, physical, engineering and social and behavioral scientists will be needed to address this problem over the next several decades.

Entities:  

Keywords:  Epidemiology; biomarkers; carcinogenesis; cardiovascular; genotoxicity; medicine/oncology

Mesh:

Year:  2019        PMID: 30895818      PMCID: PMC6567587          DOI: 10.1177/1535370219837903

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  45 in total

Review 1.  Translational strategies for cancer prevention in liver.

Authors:  Thomas W Kensler; Geng-Sun Qian; Jian-Guo Chen; John D Groopman
Journal:  Nat Rev Cancer       Date:  2003-05       Impact factor: 60.716

2.  Chemistry: Perkin, the mauve maker.

Authors:  Philip Ball
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

4.  A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades.

Authors:  Yasuhito Tanaka; Kousuke Hanada; Masashi Mizokami; Anthony E T Yeo; J Wai-Kuo Shih; Takashi Gojobori; Harvey J Alter
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

Review 5.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 6.  Alcohol and hepatocellular carcinoma.

Authors:  Timothy R Morgan; Sarathy Mandayam; M Mazen Jamal
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 7.  Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas.

Authors:  Thomas W Kensler; Patricia A Egner; Jin-Bing Wang; Yuan-Rong Zhu; Bao-Chu Zhang; Pei-Xin Lu; Jian-Guo Chen; Geng-Sun Qian; Shuang-Yuan Kuang; Peta E Jackson; Stephen J Gange; Lisa P Jacobson; Alvaro Muñoz; John D Groopman
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

8.  Trends in the incidence of cancer in Qidong, China, 1978-2002.

Authors:  Jian-Guo Chen; Jian Zhu; Donald Maxwell Parkin; Yong-Hui Zhang; Jian-Hua Lu; Yuan-Rong Zhu; Tao-Yang Chen
Journal:  Int J Cancer       Date:  2006-09-15       Impact factor: 7.396

Review 9.  Molecular viral oncology of hepatocellular carcinoma.

Authors:  Timothy M Block; Anand S Mehta; Claus J Fimmel; Robert Jordan
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

Review 10.  Mechanisms of synergy between alcohol and hepatitis C virus.

Authors:  Ashwani K Singal; Bhupinder S Anand
Journal:  J Clin Gastroenterol       Date:  2007-09       Impact factor: 3.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.